Tower Research Capital LLC (Trc) Avidity Biosciences, Inc. Transaction History

Tower Research Capital LLC (Trc)

$4.87 Billion
Q4 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 26,029 shares of RNA stock, worth $797,528. This represents 0.02% of its overall portfolio holdings.

Number of Shares

26,029

Previous 1,214 2044.07%

Holding current value

$797,528

Previous $55,000 1274.55%

% of portfolio

0.02%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$29.08 - $52.5 $721,620 - $1.3 Million	24,815 Added 2044.07%	26,029 $756,000
Q3 2024 Nov 14, 2024	SELL	$37.21 - $48.14 $599,601 - $775,727	-16,114 Reduced 92.99%	1,214 $55,000
Q2 2024 Aug 13, 2024	BUY	$22.73 - $40.85 $379,113 - $681,337	16,679 Added 2569.95%	17,328 $707,000
Q1 2024 May 15, 2024	SELL	$9.16 - $25.52 $191,526 - $533,597	-20,909 Reduced 96.99%	649 $16,000
Q4 2023 Feb 13, 2024	BUY	$4.87 - $9.37 $90,255 - $173,654	18,533 Added 612.66%	21,558 $195,000
Q3 2023 Nov 14, 2023	SELL	$6.3 - $11.35 $79,033 - $142,385	-12,545 Reduced 80.57%	3,025 $19,000
Q2 2023 Aug 14, 2023	BUY	$10.62 - $17.34 $94,836 - $154,846	8,930 Added 134.49%	15,570 $172,000
Q1 2023 May 09, 2023	SELL	$15.35 - $25.65 $174,406 - $291,435	-11,362 Reduced 63.12%	6,640 $102,000
Q4 2022 Feb 10, 2023	BUY	$10.06 - $22.66 $77,622 - $174,844	7,716 Added 75.01%	18,002 $400,000
Q3 2022 Nov 10, 2022	SELL	$15.46 - $23.43 $11,239 - $17,033	-727 Reduced 6.6%	10,286 $168,000
Q2 2022 Aug 15, 2022	BUY	$11.18 - $20.5 $107,551 - $197,210	9,620 Added 690.6%	11,013 $160,000
Q1 2022 May 12, 2022	SELL	$14.2 - $23.78 $43,551 - $72,933	-3,067 Reduced 68.77%	1,393 $26,000
Q4 2021 Feb 14, 2022	BUY	$20.4 - $28.66 $71,400 - $100,310	3,500 Added 364.58%	4,460 $106,000
Q3 2021 Nov 15, 2021	SELL	$18.16 - $25.21 $100,134 - $139,007	-5,514 Reduced 85.17%	960 $24,000
Q2 2021 Aug 16, 2021	BUY	$19.62 - $29.26 $99,198 - $147,938	5,056 Added 356.56%	6,474 $160,000
Q1 2021 May 17, 2021	BUY	$20.28 - $28.15 $6,084 - $8,445	300 Added 26.83%	1,418 $31,000
Q4 2020 Feb 16, 2021	SELL	$24.73 - $35.12 $37,342 - $53,031	-1,510 Reduced 57.46%	1,118 $29,000
Q3 2020 Nov 16, 2020	BUY	$23.35 - $35.94 $61,363 - $94,450	2,628 New	2,628 $74,000

Others Institutions Holding RNA

# of Institutions

258

Shares Held

108M

Call Options Held

517K

Put Options Held

717K

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $1.6B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Avidity Biosciences, Inc. Transaction History